HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC label reg comment period extension requests likely to be denied -- FDA's Weintraub.

This article was originally published in The Rose Sheet

Executive Summary

COSMETIC DRUG OTC LABELING REG EXEMPTION POSSIBLE, FDA Office of Drug Evaluation V Director Michael Weintraub, MD, suggested at a May 1 Nonprescription Drug Manufacturers Association industry briefing in New York City. Weintraub said FDA is "going to consider" writing a blanket exemption for cosmetic drugs into its final rule on OTC labeling. The Cosmetic, Toiletry and Fragrance Association has submitted a formal request to the agency that special labeling regs be developed for these products ("The Rose Sheet" Oct. 9, 1995, p. 5).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004121

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel